Trial reportScientific reports2026
Sex-specific effects of progressive whole-body vibration combined with active exercises on muscle mass, strength, and function in sarcopenic older adults.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Whole-body vibration (WBV) is a low-strain alternative to resistance training for improving muscle function in older adults, but evidence on progressive frequency protocols and sex-specific effects remains limited. This study investigated the effects of an eight-week WBV program on muscle mass, strength, and functional performance in sarcopenic older adults, with follow-up assessments for sustained benefits. Fifty-six participants (≥ 60 years) classified by EWGSOP2 criteria were randomly assigned to WBV or control groups (n = 28 each, 14 per gender). The WBV group performed dynamic squats with progressive frequency (15-40 Hz) and amplitude (1.2-1.8 mm), while the control group performed identical exercises without vibration. Both groups completed upper and lower limb active exercises thrice weekly for eight weeks. WBV significantly improved skeletal muscle index in females, with a significant time × intervention interaction (p < 0.001) that remained after BMI adjustment (p < 0.001), but not in males (p > 0.05). Physical Performance Test scores had a significant time × intervention interaction in both sex (p < 0.05); after BMI adjustment, the effect remained strong in females (p < 0.001) but was smaller yet significant in males (p = 0.013). Timed Up and Go performance improved in females (interaction: p = 0.001 after adjustment), while the effect in males was not significant (p = 0.972). In females, right leg quadriceps strength increased significantly after BMI adjustment (p < 0.001), with a significant interaction in the left leg (p = 0.034); no significant effects were seen in males (p > 0.05). A reduction in fear of falling (FES-I) was observed in females (p = 0.025), but the pattern of improvement over time did not differ significantly from controls (p = 0.054). For female grip strength, a significant time × intervention interaction was found for the right hand after adjustment (p = 0.002); no significant effects were found in males. While functional improvements were often maintained at follow-up in females, gains in muscle mass and strength showed some decline. These findings indicate that WBV combined with active exercise appears more beneficial for older women with sarcopenia, showing more consistent improvements in muscle mass and strength. Additionally, TUG time reduced below fall-risk threshold. However, sustained training may be necessary to maintain long-term benefits, and larger clinical trials are required to confirm the generalizability of these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.